The PD-L1 expression is related to unfavorable prognosis in many tumors, including bladder cancer, non-small cell lung carcinoma (NSCLC), and kidney cancer [11,12,13,14,15,16]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.